Notable findings include: In the SURMOUNT-1 trial of tirzepatide for the treatment of obesity, secondary findings showed improvements in the GLP-1 treatment group in systolic blood pressure (-7.2mm Hg), diastolic blood pressure (-4.8mm Hg), triglycerides (-24.8mg/dl), fasting insulin (-42.9mIU liter), and total cholesterol (-4.8mg/dl)
It cannot revive follicles that are completely destroyed, but it can stimulate regrowth in thinning regions
Mild diuretic rebound
Hydrating ingredients like glycerin, aloe vera, or hyaluronic acid can also help the skin look smoother and brighter
Characterization of ferroptosis in murine models of hemochromatosis
Cellular energy, mitochondrial support, recovery, and longevity, dispensed exclusively through licensed 503A compounding pharmacies